logo
It's a bad time to launch first-time funds, but that isn't stopping investors

It's a bad time to launch first-time funds, but that isn't stopping investors

Axios17-06-2025
Conventional wisdom is that now is a terrible time for private market investors to launch first-time funds. But that isn't stopping a slew of folks from trying.
The big picture: Limited partners are seeing a wave of general partners spinouts, and many expect that the trend will outpace industry consolidation, according to a recent Coller Capital survey.
One major reason, they say, is that firms have done a lousy job nurturing homegrown talent.
Coller's questionnaire didn't go a level deeper, but it's not too hard to read "tilted fund economics" in that response. Everyone inside a firm knows who brings in the home run deals, and if that rainmaker doesn't get compensated like one.
By the numbers: 38% of LP respondents said they expect the number of new managers to increase over the next three to five years, compared to just 33% who say they expect it to decrease.
The "increase" cohort was particularly strong among Asia-Pacific respondents (64%).
Coller also found that 36% of LPs report the number of spinout funds within their portfolio has increased within the past few years, while only 3% said it's decreased. The majority said it's remained flat.
Zoom out: Raising a first-time fund is never easy, and many believe the process has become even more challenging as LPs have sought to shrink their manager rosters — preferring to plug larger amounts into multi-strategy firms.
Plus the VC/PE distribution drought that's reduced the amount of available LP capital.
On the other hand, LPs also worry that too much mega-fund exposure won't allow them to beat industry benchmarks — which means many are willing to bet on a few emerging managers to provide alpha.
What they're saying: "It's like the old phrase: people hate Congress but love their congressperson," a veteran LP tells me. "A lot of people are super risk averse (and liquidity crunched) right now, making emerging funds a challenge to raise, but known quantities de-risk the decision for those who are able to put out capital."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Asia-Pacific stocks set for lower open as investors recent weigh trade developments
Asia-Pacific stocks set for lower open as investors recent weigh trade developments

CNBC

time27 minutes ago

  • CNBC

Asia-Pacific stocks set for lower open as investors recent weigh trade developments

Asia-Pacific markets are set for a lower open as investors weigh recent trade developments. Good morning from Singapore. Asia markets were set for a muted open Friday. Japan's benchmark Nikkei 225 was set to start the trading day lower, with the futures contract in Chicago at 41,740 and its counterpart in Osaka at 41,640, against the index's last close at 41,826.34. Futures for Hong Kong's Hang Seng index stood at 25,505, pointing to a weaker open compared with the HSI's last close of 25,667.18. Australia's S&P/ASX 200 was also on track to start the day lower with futures tied to the benchmark at 8,637, compared with its last close of 8,709.4. — Lee Ying Shan The S&P 500 and the Nasdaq Composite ended Thursday's session with fresh record closes after scoring new all-time intraday highs earlier in the trading day. The broad market index closed 0.07% higher to end at 6,363.35, while the tech-heavy Nasdaq inched up 0.18% to finish at 21,057.96. However, the blue-chip Dow Jones Industrial Average pulled back 316.38 points, or 0.7%, to settle at 44,693.91. — Sean Conlon

Weyerhaeuser Reports Second Quarter 2025 Results
Weyerhaeuser Reports Second Quarter 2025 Results

Yahoo

time3 hours ago

  • Yahoo

Weyerhaeuser Reports Second Quarter 2025 Results

SEATTLE, July 24, 2025 /PRNewswire/ -- Weyerhaeuser Company (NYSE: WY) today reported its second quarter 2025 financial results. The company's earnings release and associated materials are available on the Investors section of the company's website, In addition, the earnings release has been furnished on a Form 8-K with the U.S. Securities and Exchange Commission and is available at EARNINGS CALL INFORMATIONThe company will hold a live conference call at 7 a.m. Pacific (10 a.m. Eastern) on July 25, 2025, to discuss second quarter results. To access the live webcast and presentation, go to the Investors section on on July 25, 2025. To join the conference call from within North America, dial 877-407-0792 (access code: 13748397) at least 15 minutes prior to the call. Those calling from outside North America should dial 201-689-8263 (access code: 13748397). Replays will be available for two weeks at 844-512-2921 (access code: 13748397) from within North America, and at 412-317-6671 (access code: 13748397) from outside North America. ABOUT WEYERHAEUSERWeyerhaeuser Company, one of the world's largest private owners of timberlands, began operations in 1900 and today owns or controls approximately 10.4 million acres of timberlands in the U.S., as well as additional public timberlands managed under long-term licenses in Canada. Weyerhaeuser has been a global leader in sustainability for more than a century and manages 100 percent of its timberlands on a fully sustainable basis in compliance with internationally recognized sustainable forestry standards. Weyerhaeuser is also one of the largest manufacturers of wood products in North America and operates additional business lines around product distribution, climate solutions, real estate, energy and natural resources, among others. In 2024, the company generated $7.1 billion in net sales and employed approximately 9,400 people who serve customers worldwide. Operated as a real estate investment trust, Weyerhaeuser's common stock trades on the New York Stock Exchange under the symbol WY. Learn more at For more information contact:Analysts – Andy Taylor, 206-539-3907Media – Nancy Thompson, 919-861-0342 View original content to download multimedia: SOURCE Weyerhaeuser

Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025
Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025

Yahoo

time4 hours ago

  • Yahoo

Sight Sciences to Report Second Quarter 2025 Financial Results on August 7, 2025

MENLO PARK, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ('Sight Sciences' or the 'Company'), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients' lives, today announced it will report financial results for the second quarter ended June 30, 2025, after the market close on Thursday, August 7, 2025. The Company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at on the Investors page in the News & Events section. The webcast will be available for replay for at least 90 days after the event. About Sight Sciences Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients' lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world's most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company's OMNI® Surgical System and OMNI® Edge Surgical System are implant-free, minimally invasive glaucoma surgery technologies (i) indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The OMNI Surgical System is CE Marked for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world's leading cause of irreversible blindness. The SION® Surgical System is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company's TearCare® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit for more information. Sight Sciences, the Sight Sciences logo, TearCare, and SmartLids are trademarks of Sight Sciences registered in the United States. OMNI and SION are trademarks of Sight Sciences registered in the United States, European Union and other territories. © 2025 Sight Sciences. All rights reserved. Media contact:pr@ Investor contact:Philip TaylorGilmartin in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store